Assignee
METROPHARM AG
CH·0 granted patents·3 pending applications·0 citations·filing 2022–2023
Top patents by PatentIndex Score
3 records- 0159US2025064801A1Use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the treatment of congenital muscular dystrophiesMETROPHARM AG·Filed 2023·Application pending·0 cites
- 0259US2025064800A1Combination of budesonide and 5-amino-2,3-dihydro-1,4-phthalazinedioneMETROPHARM AG·Filed 2023·Application pending·0 cites
- 0355US2025032486A1Combination of 5-amino-2,3-dihydro-1,4-phtalazinedione and a 6'-methoxycinchonan-9-ol for use in the treatment of coronaviral infectionsMETROPHARM AG·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when METROPHARM AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →